IP Library Granted Patent US 9,579,354
Granted Patent B2
US 9,579,354 · App. 14/373,810 · Granted Feb 28, 2017

Sandalwood oil and its uses related to clostridium infections

Inventors: Ian Clements (San Antonio, TX); Paul Castella (San Antonio, TX); Corey Levenson (San Antonio, TX)
Assignee: Santalis Pharmaceuticals, Inc.
A61K36/185A01N65/08A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,579,354
App. No.
14/373,810
Granted
Feb 28, 2017
Kind
B2
Abstract

Provided herein are methods of using therapeutically effective compositions of sandalwood oil to treat, prevent or reduce the recurrence of Clostridium infections.

Claims (9)

1. A method of treating a Clostridium difficile infection in a subject in need thereof, said method comprising administering to the subject a composition comprising a therapeutically effective amount of sandalwood oil.

2. The method of claim 1 , wherein the infection is in the digestive tract of the subject.

3. The method of claim 1 , wherein the sandalwood oil is from Santalum album or Santalum spicatum or a combination thereof.

4. The method of claim 1 , wherein the composition comprises about 0.03% to about 100% sandalwood oil (w/w).

5. The method of claim 4 , wherein the composition comprises about 0.03% to about 1% sandalwood oil (w/w).

6. The method of claim 5 , wherein the composition comprises about 0.03% to about 0.5% sandalwood oil (w/w).

7. The method of claim 1 , wherein the composition comprising the therapeutically effective amount of sandalwood oil further comprises a pharmaceutical carrier.

8. The method of claim 7 wherein the pharmaceutical carrier is a high molecular weight polyethylene glycol.

9. The method of claim 1 , wherein the composition is administered as a tablet, a capsule, a liquid, or a suppository.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 23, 2018
From: BTA INSTITUTIONAL SERVICES AUSTRALIA LIMITED
To: SANTALIS HEALTHCARE CORPORATION; SANTALIS PHARMACEUTICALS, INC.
Reel/Frame 047282/0428 →
SECURITY INTEREST Recorded Oct 23, 2018
From: SANTALIS HEALTHCARE CORPORATION; SANTALIS PHARMACEUTICALS, INC.
To: GLOBAL LOAN AGENCY SERVICES AUSTRALIA NOMINEES PTY LTD
Reel/Frame 047282/0532 →
PATENT SECURITY AGREEMENT Recorded Aug 1, 2016
From: SANTALIS PHARMACEUTICALS, INC.; SANTALIS HEALTHCARE CORPORATION
To: BTA INSTITUTIONAL SERVICES AUSTRALIA LIMITED
Reel/Frame 039535/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2014
From: CLEMENTS, IAN; CASTELLA, PAUL; LEVENSON, COREY
To: SANTALIS PHARMACEUTICALS, INC.
Reel/Frame 033424/0847 →
Continuity (2)
Provisional Application 61589601 · Jan 23, 2012
Related Publication 20150238551A1 · Aug 27, 2015